Status:

COMPLETED

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

Lead Sponsor:

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions:

Hematological Malignancies

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate the engraftment of donor hemopoiesis (proportion of transplanted patients with successful engraftment at day +42) in adult patients affected by high risk hemat...

Detailed Description

For many hematological malignancies, hemopoietic stem cell (HSC) transplant is the only possible treatment. The source of HSC is often bone marrow (BM) or, in the past 10 years, peripheral blood cell ...

Eligibility Criteria

Inclusion

  • Age between 18 and 65 years.
  • Patients affected by hematological malignancies without a HLA identical sibling donor or unrelated donor.
  • Informed consent.

Exclusion

  • Patients with ECOG \< 2.
  • Patients with blood creatine \> 2 mg/dl or with transaminase or cholestase index \> 5 times compared to normality upper limits.
  • Patients with Cardiac Fraction Ejection \< 40%.
  • Patients with DLCO \< 60% or Diffusing Lung Capacity of carbon monoxide attesting a severe pulmonary insufficiency.
  • Patients with peripheral blast cell count over 10%.
  • Second neoplasia diagnosed no more than 2 years before.
  • Patients with active or suspected infection by fungi for which a therapeutic treatment is ongoing.
  • HIV positive patients.
  • HCV-RNA and HBV-RNA positive patients (it is possible to enrol them after discussion with the Principal Investigator).
  • Pregnant or lactating women.
  • Severe mental diseases.

Key Trial Info

Start Date :

April 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2013

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT00886522

Start Date

April 1 2009

End Date

May 1 2013

Last Update

March 19 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital

Bologna, Italy, 40138